Business news
- Ukraine, trade, pandas: What China's Xi and France's Macron discussed in Beijing - China said it is open to importing more high-quality goods from France while urging a "fair, conducive environment" for Chinese businesses in the European nation.
- Inside Europe’s biggest rare earths factory on Russia's doorstep - Developed by Canada's Neo Performance Materials, Europe's largest rare earths facility sits in Estonia's border city of Narva.
- Software startup deploys Singapore’s first quantum computer for commercial use - Singapore-based software firm Horizon Quantum Computing has become the first private firm to deploy a quantum computer for commercial use in the city-state.
- Asia markets mostly rise after Wall Street gains on rate-cut hopes fueled by weak jobs data - The ADP report is the last jobs picture the Federal Reserve gets before it meets Dec. 9-10. Markets are now pricing in an 89% chance of a cut.
- Bank of Japan faces a policy dilemma as government bond yields keep hitting new highs - Experts said the rise in yields is due to inflation running above target, hawkish remarks from the Bank of Japan and an expansionary fiscal policy.
- Trump's South Korea tariff cuts are major boost for Hyundai and GM - The Trump administration said the tariff rate for vehicles from South Korea will drop to 15% as part of a trade deal.
- Salesforce beats on earnings, issues better-than-expected revenue forecast - Salesforce said its Agentforce artificial intelligence business is generating over $500 million in annualized revenue.
- Micron stops selling memory to consumers as demand spikes from AI chips - Demand driven by the AI infrastructure boom is creating shortages for certain products like memory.
- Jeffrey Epstein island photos and videos released as top banks share files with House Oversight Committee - The release comes as Attorney General Pam Bondi is on a deadline to publicly share files related to Epstein and his convicted accomplice Ghislaine Maxwell.
- Medicare prescription drug costs may change in 2026 — what beneficiaries need to know - For retirees who rely on prescription drugs, experts say it's a good time to evaluate the cost of those treatments for next year.